These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2476709)

  • 1. Substance P and peripheral inflammatory hyperalgesia.
    Nakamura-Craig M; Smith TW
    Pain; 1989 Jul; 38(1):91-98. PubMed ID: 2476709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw.
    Nakamura-Craig M; Gill BK
    Neurosci Lett; 1991 Mar; 124(1):49-51. PubMed ID: 1713317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P: does it produce analgesia or hyperalgesia?
    Oehme P; Hilse H; Morgenstern E; Göres E
    Science; 1980 Apr; 208(4441):305-7. PubMed ID: 6154313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice.
    Uda R; Horiguchi S; Ito S; Hyodo M; Hayaishi O
    Brain Res; 1990 Feb; 510(1):26-32. PubMed ID: 2322844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system.
    Taiwo YO; Bjerknes LK; Goetzl EJ; Levine JD
    Neuroscience; 1989; 32(3):577-80. PubMed ID: 2557557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin hyperalgesia, V: a peripheral analgesic receptor for opiates.
    Ferreira SH; Molina N; Vettore O
    Prostaglandins; 1982 Jan; 23(1):53-60. PubMed ID: 6278540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin hyperalgesia, IV: a metabolic process.
    Ferreira SH; Lorenzetti BB
    Prostaglandins; 1981 May; 21(5):789-92. PubMed ID: 6280243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia.
    Wajima Z; Hua XY; Yaksh TL
    Brain Res; 2000 Sep; 877(2):314-21. PubMed ID: 10986346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat.
    Taiwo YO; Levine JD
    Brain Res; 1989 Jul; 492(1-2):397-9. PubMed ID: 2665905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia.
    Dallob A; Guindon Y; Goldenberg MM
    Biochem Pharmacol; 1987 Oct; 36(19):3201-4. PubMed ID: 2822047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of guanine nucleotide regulatory proteins to prostaglandin hyperalgesia in the rat.
    Taiwo YO; Levine JD
    Brain Res; 1989 Jul; 492(1-2):400-3. PubMed ID: 2502301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperalgesia onset latency suggests a hierarchy of action.
    Taiwo YO; Goetzl EJ; Levine JD
    Brain Res; 1987 Oct; 423(1-2):333-7. PubMed ID: 2823989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril does not potentiate hypotension and algesia by substance P.
    Hui SC; Ogle CW
    Clin Exp Pharmacol Physiol; 1986; 13(11-12):819-22. PubMed ID: 2435436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.
    Parenti C; Aricò G; Ronsisvalle G; Scoto GM
    Peptides; 2012 Apr; 34(2):412-8. PubMed ID: 22306475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids.
    Hua XY; Chen P; Marsala M; Yaksh TL
    Neuroscience; 1999 Mar; 89(2):525-34. PubMed ID: 10077333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
    Bianchi M; Franchi S; Ferrario P; Sotgiu ML; Sacerdote P
    Eur J Pain; 2008 Apr; 12(3):284-92. PubMed ID: 17664076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats.
    Okano K; Kuraishi Y; Satoh M
    Jpn J Pharmacol; 1998 Jan; 76(1):15-22. PubMed ID: 9517400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptive effect of subcutaneously injected interleukin-12 is mediated by endothelin (ET) acting on ETB receptors in rats.
    Verri WA; Molina RO; Schivo IR; Cunha TM; Parada CA; Poole S; Ferreira SH; Cunha FQ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):609-15. PubMed ID: 16024732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia.
    Safieh-Garabedian B; Poole S; Allchorne A; Winter J; Woolf CJ
    Br J Pharmacol; 1995 Aug; 115(7):1265-75. PubMed ID: 7582555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice.
    Goettl VM; Larson AA
    Pain; 1996 Oct; 67(2-3):435-41. PubMed ID: 8951939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.